Cardiovascular Systems (CSII) Reaches $23.24 52 Week Low; BCE Inc. (USA) (BCE) Covered By 4 Bulls

November 14, 2017 - By Marie Mckinney

The stock of Cardiovascular Systems Inc (NASDAQ:CSII) hit a new 52-week low and has $21.85 target or 6.00% below today’s $23.24 share price. The 6 months bearish chart indicates high risk for the $768.73

million company. The 1-year low was reported on Nov, 14 by Barchart.com. If the $21.85 price target is reached, the company will be worth $46.12M less. About 37,482 shares traded. Cardiovascular Systems Inc (NASDAQ:CSII) has risen 113.78% since November 14, 2016 and is uptrending. It has outperformed by 97.08% the S&P500.

Among 8 analysts covering BCE Inc. (NYSE:BCE), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. BCE Inc. had 20 analyst reports since August 4, 2015 according to SRatingsIntel. The firm earned “Sector Perform” rating on Monday, January 9 by RBC Capital Markets. The stock of BCE Inc. (USA) (NYSE:BCE) has “Overweight” rating given on Tuesday, March 21 by Barclays Capital. The stock has “Buy” rating by Citigroup on Thursday, April 6. The company was maintained on Friday, August 7 by Canaccord Genuity. The stock has “Buy” rating by Goldman Sachs on Friday, December 4. Canaccord Genuity upgraded BCE Inc. (USA) (NYSE:BCE) on Friday, November 6 to “Buy” rating. The firm has “Neutral” rating by Credit Suisse given on Monday, January 4. The rating was maintained by National Bank Canada with “Sector Perform” on Friday, November 6. Citigroup downgraded the shares of BCE in report on Thursday, May 26 to “Neutral” rating. The firm earned “Underperform” rating on Tuesday, October 27 by Macquarie Research. See BCE Inc. (USA) (NYSE:BCE) latest ratings:

27/09/2017 Broker: Inc. Common Stock Rating: Morgan Stanley New Target: $62 60
03/08/2017 Broker: Barclays Capital Rating: Buy New Target: $51.0000
04/08/2017 Broker: Inc. Common Stock Rating: Barclays New Target: $47 51
18/07/2017 Broker: Inc. Common Stock Rating: Argus

BCE Inc. is a communications company. The company has market cap of $43.44 billion. The Company’s divisions include Bell Wireless, Bell Wireline and Bell Media. It has a 19 P/E ratio. The Company’s Bell Wireless segment provides wireless voice and data communications services and products to its residential, small and medium-sized business and large enterprise clients across Canada.

About 158,306 shares traded. BCE Inc. (USA) (NYSE:BCE) has declined 2.36% since November 14, 2016 and is downtrending. It has underperformed by 19.06% the S&P500.

Among 8 analysts covering Cardiovascular Systems (NASDAQ:CSII), 5 have Buy rating, 2 Sell and 1 Hold. Therefore 63% are positive. Cardiovascular Systems had 22 analyst reports since August 6, 2015 according to SRatingsIntel. As per Friday, April 1, the company rating was upgraded by Needham. On Wednesday, June 21 the stock rating was downgraded by Bank of America to “Underperform”. The company was downgraded on Thursday, September 3 by Zacks. The rating was downgraded by Leerink Swann on Thursday, October 8 to “Market Perform”. The firm has “Buy” rating by Needham given on Friday, July 14. Needham maintained it with “Buy” rating and $23 target in Wednesday, June 29 report. The stock has “Buy” rating by Needham on Thursday, January 26. The firm earned “Strong Buy” rating on Thursday, August 6 by Needham. The company was initiated on Monday, January 30 by Lake Street. The firm earned “Outperform” rating on Monday, August 22 by Leerink Swann.

Cardiovascular Systems, Inc. is a medical technology company. The company has market cap of $768.73 million. The Firm is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. It currently has negative earnings. The Firm develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>